Verstovsek, S
Talpaz, M
Ritchie, E
Wadleigh, M
Odenike, O
Jamieson, C
Stein, B
Uno, T
Mesa, R A
Article History
Received: 1 April 2016
Revised: 24 June 2016
Accepted: 4 July 2016
First Online: 1 August 2016
Competing interests
: SV has received research support from NS Pharma, Inc. MT has received research support from Ariad, BMS, Sanofi, Pfizer and Incyte. ER is part of the speakers’ bureau for Celgene and Incyte. MW has no conflicts of interest to disclose. OMO has served on the advisory committee for Incyte, CTI/Baxalta, Celgene, Spectrum and Sunesis. CJ has received research funding from J&J and CTI Biopharma. BS has served as part of the advisory committee and speakers’ bureau for Incyte and on the advisory committee for Sanofi. TU is an employee of NS Pharma, Inc. RAM has received research support from Incyte, Gilead, Celgene and NS Pharma, Inc.